Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance IncfiledCriticalTheravance Inc
Priority to MYPI9902273priorityCriticalpatent/MY128351A/en
Publication of MY128351ApublicationCriticalpatent/MY128351A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
DISCLOSED ARE MULTIBINDING COMPOUNDS WHICH ARE β2 ADRENERGIC RECEPTOR AGONISTS AND ARE USEFUL IN THE TREATMENT AND PREVENTION OF RESPIRATORY DISEASES SUCH AS ASTHMA. BRONCHITIS.THEY ARE ALSO USEFUL IN THE TREATMENT OF NERVOUS SYSTEM INJURY AND PREMATURE LABOR.MOST ILLUSTRATIVE DRAWING : (FIGURE 1)